Myo-inositol may prevent gestational diabetes in PCOS women.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22122627
Conclusion of this study
Consequently, in the control group the risk of GD occurrence was more than double compared to the myo-inositol group, with an odds ratio 2.4 (confidence interval 95%, 1.3-4.4). There was no difference between the groups in relation to secondary outcome measures. This study suggests a possible effect of myo-inositol in the primary prevention of GD in PCOS women.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study